Global Smart Precision Medicine Software Market

Smart Precision Medicine Software Comprehensive Study by Delivering Mode (Web & Cloud-based, On-premise), End User (Healthcare Providers, Research & Government Institutes, Pharmaceutical & Biotechnology Companies) Players and Region - Global Market Outlook to 2028

Smart Precision Medicine Software Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Smart Precision Medicine Software Market Scope
Precision medication software program is an essential device used by way of healthcare companies for screening prenatal aneuploidy, evaluating uncommon disorders, diagnosing infectious diseases, and figuring out therapeutic goals in neoplasms. Precision medicinal drug software program includes on premise and internet & cloud-based deployment systems used in the personalized cure and detection of diseases, such as cancers, genetic disorders, cardiac & infectious diseases, and others. Precision medicinal drug software program assists docs in selecting a remedy approach based totally on the patient’s genetic make-up and way of life habits.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledSyapse, Inc. (United States), LifeOmic Health, LLC (United States), NantHealth, Inc. (United States), Foundation Medicine, Inc. (United States), Fabric Genomics (United States), SOPHiA GENETICS SA (Switzerland), PierianDx, Inc. (United States), N-of-One, Inc. (United States), Translational Software, Inc. (United States) and Sunquest Information Systems Inc. (United States)
CAGR%


The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Smart Precision Medicine Software market throughout the predicted period.

Syapse, Inc. (United States), LifeOmic Health, LLC (United States), NantHealth, Inc. (United States), Foundation Medicine, Inc. (United States), Fabric Genomics (United States), SOPHiA GENETICS SA (Switzerland), PierianDx, Inc. (United States), N-of-One, Inc. (United States), Translational Software, Inc. (United States) and Sunquest Information Systems Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Gene42, Inc. (Canada), Tempus Labs, Inc. (United States), Flatiron Health, Inc. (United States), IBM Watson Group (United States) and Koninklijke Philips N.V. (Netherlands).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Smart Precision Medicine Software market by Type and Region with country level break-up.

On the basis of geography, the market of Smart Precision Medicine Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
In 2020, the San Antonio Partnership for Precision Therapeutics introduced funding of three collaborative COVID-19 lookup efforts in San Antonio. These initiatives will assist a sturdy basis of transformative COVID-19 lookup taking place in San Antonio. Cleveland Clinic additionally launched a genomic remedy task to pick out genetic elements that power susceptibility to the virus and use these to enhance prevention and therapeutic techniques towards the virus. Emory University researchers are additionally investigating an antiviral compound that works like Remdesivir, which inhibits viral replication.
In May 2019, Amgen, a world leader in biotechnology, and Syapse, a company providing precision medicine insights through a global network of providers, entered into a precision medicine collaboration in oncology. Under the terms of the agreement, Amgen and Syapse will develop an observational study assay. Evaluate treatment outcomes for unmet need areas in oncology. This effort will identify existing patients within the Syapse Learning Health Network who may be eligible for Amgen-sponsored clinical trials and bring these trials to community health system sites.


Influencing Trend:
Technological Advancements in the Healthcare Sector and Increased Adoption of Cloud-Based Solutions

Market Growth Drivers:
Increased Deployments of Smart Precision Medicine Software and Growth in Government Support in Smart Precision Medicine Initiatives

Challenges:
High Complexed Data Associated with Smart Precision Medicine Software

Restraints:
Lack Of Awareness about Precision Medicine Practices and Fragmented Healthcare Systems in Developing Countries and High-Cost Associated with the Deployment of Software

Opportunities:
Investigating New Treatments, Reusing Existing Medications and Separating Patients for Clinical Preliminaries

Key Target Audience
Smart Precision Medicine Software Developers, Emerging Companies, Research Professionals, End-users and Others

Report Objectives / Segmentation Covered

By Delivering Mode
  • Web & Cloud-based
  • On-premise

By End User
  • Healthcare Providers
  • Research & Government Institutes
  • Pharmaceutical & Biotechnology Companies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Deployments of Smart Precision Medicine Software
      • 3.2.2. Growth in Government Support in Smart Precision Medicine Initiatives
    • 3.3. Market Challenges
      • 3.3.1. High Complexed Data Associated with Smart Precision Medicine Software
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in the Healthcare Sector
      • 3.4.2. Increased Adoption of Cloud-Based Solutions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Smart Precision Medicine Software, by Delivering Mode, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Smart Precision Medicine Software (Value)
      • 5.2.1. Global Smart Precision Medicine Software by: Delivering Mode (Value)
        • 5.2.1.1. Web & Cloud-based
        • 5.2.1.2. On-premise
      • 5.2.2. Global Smart Precision Medicine Software by: End User (Value)
        • 5.2.2.1. Healthcare Providers
        • 5.2.2.2. Research & Government Institutes
        • 5.2.2.3. Pharmaceutical & Biotechnology Companies
      • 5.2.3. Global Smart Precision Medicine Software Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Smart Precision Medicine Software: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Syapse, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. LifeOmic Health, LLC (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. NantHealth, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Foundation Medicine, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Fabric Genomics (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. SOPHiA GENETICS SA (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. PierianDx, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. N-of-One, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Translational Software, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sunquest Information Systems Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Smart Precision Medicine Software Sale, by Delivering Mode, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Smart Precision Medicine Software (Value)
      • 7.2.1. Global Smart Precision Medicine Software by: Delivering Mode (Value)
        • 7.2.1.1. Web & Cloud-based
        • 7.2.1.2. On-premise
      • 7.2.2. Global Smart Precision Medicine Software by: End User (Value)
        • 7.2.2.1. Healthcare Providers
        • 7.2.2.2. Research & Government Institutes
        • 7.2.2.3. Pharmaceutical & Biotechnology Companies
      • 7.2.3. Global Smart Precision Medicine Software Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Smart Precision Medicine Software: by Delivering Mode(USD Million)
  • Table 2. Smart Precision Medicine Software Web & Cloud-based , by Region USD Million (2017-2022)
  • Table 3. Smart Precision Medicine Software On-premise , by Region USD Million (2017-2022)
  • Table 4. Smart Precision Medicine Software: by End User(USD Million)
  • Table 5. Smart Precision Medicine Software Healthcare Providers , by Region USD Million (2017-2022)
  • Table 6. Smart Precision Medicine Software Research & Government Institutes , by Region USD Million (2017-2022)
  • Table 7. Smart Precision Medicine Software Pharmaceutical & Biotechnology Companies , by Region USD Million (2017-2022)
  • Table 8. South America Smart Precision Medicine Software, by Country USD Million (2017-2022)
  • Table 9. South America Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 10. South America Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 11. Brazil Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 12. Brazil Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 13. Argentina Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 14. Argentina Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 15. Rest of South America Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 16. Rest of South America Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 17. Asia Pacific Smart Precision Medicine Software, by Country USD Million (2017-2022)
  • Table 18. Asia Pacific Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 19. Asia Pacific Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 20. China Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 21. China Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 22. Japan Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 23. Japan Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 24. India Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 25. India Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 26. South Korea Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 27. South Korea Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 28. Taiwan Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 29. Taiwan Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 30. Australia Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 31. Australia Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 32. Rest of Asia-Pacific Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 33. Rest of Asia-Pacific Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 34. Europe Smart Precision Medicine Software, by Country USD Million (2017-2022)
  • Table 35. Europe Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 36. Europe Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 37. Germany Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 38. Germany Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 39. France Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 40. France Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 41. Italy Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 42. Italy Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 43. United Kingdom Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 44. United Kingdom Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 45. Netherlands Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 46. Netherlands Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 47. Rest of Europe Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 48. Rest of Europe Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 49. MEA Smart Precision Medicine Software, by Country USD Million (2017-2022)
  • Table 50. MEA Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 51. MEA Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 52. Middle East Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 53. Middle East Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 54. Africa Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 55. Africa Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 56. North America Smart Precision Medicine Software, by Country USD Million (2017-2022)
  • Table 57. North America Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 58. North America Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 59. United States Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 60. United States Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 61. Canada Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 62. Canada Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 63. Mexico Smart Precision Medicine Software, by Delivering Mode USD Million (2017-2022)
  • Table 64. Mexico Smart Precision Medicine Software, by End User USD Million (2017-2022)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Smart Precision Medicine Software: by Delivering Mode(USD Million)
  • Table 76. Smart Precision Medicine Software Web & Cloud-based , by Region USD Million (2023-2028)
  • Table 77. Smart Precision Medicine Software On-premise , by Region USD Million (2023-2028)
  • Table 78. Smart Precision Medicine Software: by End User(USD Million)
  • Table 79. Smart Precision Medicine Software Healthcare Providers , by Region USD Million (2023-2028)
  • Table 80. Smart Precision Medicine Software Research & Government Institutes , by Region USD Million (2023-2028)
  • Table 81. Smart Precision Medicine Software Pharmaceutical & Biotechnology Companies , by Region USD Million (2023-2028)
  • Table 82. South America Smart Precision Medicine Software, by Country USD Million (2023-2028)
  • Table 83. South America Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 84. South America Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 85. Brazil Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 86. Brazil Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 87. Argentina Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 88. Argentina Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 89. Rest of South America Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 90. Rest of South America Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 91. Asia Pacific Smart Precision Medicine Software, by Country USD Million (2023-2028)
  • Table 92. Asia Pacific Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 93. Asia Pacific Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 94. China Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 95. China Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 96. Japan Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 97. Japan Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 98. India Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 99. India Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 100. South Korea Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 101. South Korea Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 102. Taiwan Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 103. Taiwan Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 104. Australia Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 105. Australia Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 106. Rest of Asia-Pacific Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 107. Rest of Asia-Pacific Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 108. Europe Smart Precision Medicine Software, by Country USD Million (2023-2028)
  • Table 109. Europe Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 110. Europe Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 111. Germany Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 112. Germany Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 113. France Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 114. France Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 115. Italy Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 116. Italy Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 117. United Kingdom Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 118. United Kingdom Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 119. Netherlands Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 120. Netherlands Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 121. Rest of Europe Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 122. Rest of Europe Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 123. MEA Smart Precision Medicine Software, by Country USD Million (2023-2028)
  • Table 124. MEA Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 125. MEA Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 126. Middle East Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 127. Middle East Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 128. Africa Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 129. Africa Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 130. North America Smart Precision Medicine Software, by Country USD Million (2023-2028)
  • Table 131. North America Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 132. North America Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 133. United States Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 134. United States Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 135. Canada Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 136. Canada Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 137. Mexico Smart Precision Medicine Software, by Delivering Mode USD Million (2023-2028)
  • Table 138. Mexico Smart Precision Medicine Software, by End User USD Million (2023-2028)
  • Table 139. Research Programs/Design for This Report
  • Table 140. Key Data Information from Secondary Sources
  • Table 141. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Smart Precision Medicine Software: by Delivering Mode USD Million (2017-2022)
  • Figure 5. Global Smart Precision Medicine Software: by End User USD Million (2017-2022)
  • Figure 6. South America Smart Precision Medicine Software Share (%), by Country
  • Figure 7. Asia Pacific Smart Precision Medicine Software Share (%), by Country
  • Figure 8. Europe Smart Precision Medicine Software Share (%), by Country
  • Figure 9. MEA Smart Precision Medicine Software Share (%), by Country
  • Figure 10. North America Smart Precision Medicine Software Share (%), by Country
  • Figure 11. Global Smart Precision Medicine Software share by Players 2022 (%)
  • Figure 12. Global Smart Precision Medicine Software share by Players (Top 3) 2022(%)
  • Figure 13. Global Smart Precision Medicine Software share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Syapse, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Syapse, Inc. (United States) Revenue: by Geography 2022
  • Figure 17. LifeOmic Health, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 18. LifeOmic Health, LLC (United States) Revenue: by Geography 2022
  • Figure 19. NantHealth, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. NantHealth, Inc. (United States) Revenue: by Geography 2022
  • Figure 21. Foundation Medicine, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Foundation Medicine, Inc. (United States) Revenue: by Geography 2022
  • Figure 23. Fabric Genomics (United States) Revenue, Net Income and Gross profit
  • Figure 24. Fabric Genomics (United States) Revenue: by Geography 2022
  • Figure 25. SOPHiA GENETICS SA (Switzerland) Revenue, Net Income and Gross profit
  • Figure 26. SOPHiA GENETICS SA (Switzerland) Revenue: by Geography 2022
  • Figure 27. PierianDx, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. PierianDx, Inc. (United States) Revenue: by Geography 2022
  • Figure 29. N-of-One, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. N-of-One, Inc. (United States) Revenue: by Geography 2022
  • Figure 31. Translational Software, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Translational Software, Inc. (United States) Revenue: by Geography 2022
  • Figure 33. Sunquest Information Systems Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Sunquest Information Systems Inc. (United States) Revenue: by Geography 2022
  • Figure 35. Global Smart Precision Medicine Software: by Delivering Mode USD Million (2023-2028)
  • Figure 36. Global Smart Precision Medicine Software: by End User USD Million (2023-2028)
  • Figure 37. South America Smart Precision Medicine Software Share (%), by Country
  • Figure 38. Asia Pacific Smart Precision Medicine Software Share (%), by Country
  • Figure 39. Europe Smart Precision Medicine Software Share (%), by Country
  • Figure 40. MEA Smart Precision Medicine Software Share (%), by Country
  • Figure 41. North America Smart Precision Medicine Software Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Syapse, Inc. (United States)
  • LifeOmic Health, LLC (United States)
  • NantHealth, Inc. (United States)
  • Foundation Medicine, Inc. (United States)
  • Fabric Genomics (United States)
  • SOPHiA GENETICS SA (Switzerland)
  • PierianDx, Inc. (United States)
  • N-of-One, Inc. (United States)
  • Translational Software, Inc. (United States)
  • Sunquest Information Systems Inc. (United States)
Additional players considered in the study are as follows:
Gene42, Inc. (Canada) , Tempus Labs, Inc. (United States) , Flatiron Health, Inc. (United States) , IBM Watson Group (United States) , Koninklijke Philips N.V. (Netherlands)
Select User Access Type

Key Highlights of Report


May 2023 203 Pages 50 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Smart Precision Medicine Software Market Quantitative research analysis
Global Smart Precision Medicine Software Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Smart Precision Medicine Software Market are by end use application [].
The Smart Precision Medicine Software Market is gaining popularity and expected to see strong valuation by 2028.
  • Increased Deployments of Smart Precision Medicine Software
  • Growth in Government Support in Smart Precision Medicine Initiatives

Know More About Global Smart Precision Medicine Software Market Report?

Have a Query? Click Here

Other Related Reports

Virtual Travel Platform Comprehensive Study by Type (Desktop-based, Mobile Apps, VR Headset-based), Application (Education, Traveling), Platform (Windows, Android, IOS, Others) Players and Region - G...
$ 3800
Track Carbon Footprint APP Comprehensive Study by Application (IT & Telecom, Energy & Utilities, Manufacturing, Transportation, Building & Construction, Others), Technology (AI, ML, IoT), Device (Mob...
$ 3800
Safety Apps for Students Comprehensive Study by Application (Campus safety, Cyber security, Domestic Violence, Physical Health, Mental Health, Other), Business Model (Subscription Based, Advertisemen...
$ 3800
Decentralized Identifiers Comprehensive Study by Type (Private DIDs, Public DIDs), Application (Finance, Government, Healthcare, Others), End User (Enterprise, Individual) Players and Region - Global...
$ 3500
Headless Content Management System Comprehensive Study by Type (On-Premise Headless CMS, Cloud Install Headless CMS, Cloud Multi-Tenant Headless CMS), Application (SMEs, Large Enterprises), Industry ...
$ 3500
Contract Analysis Software Comprehensive Study by Application (Government, Retail and e-commerce, Healthcare and Life Sciences, Banking, Financial Services and Insurance (BFSI), Transportation and Lo...
$ 3800